Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

References

• Pierpont TM, Limper CB, Richards KL. Past, present, and future of rituximab—the world’s first oncology monoclonal antibody therapy. Front Oncol. 2018;8:163.
   PubMed Web of Science ®Google Scholar
• Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol. 2010;10:236–247.
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Kosmas C, et al. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases. Leukemia. 2002;16:2167–2169.
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Stavroyianni N, et al. Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases. Leuk Res. 2002;26:597–600.
   PubMed Web of Science ®Google Scholar
• Ram R, Ben-Bassat I, Shpilberg O, et al. The late adverse events of rituximab therapy - rare but there! Leuk Lymphoma. 2009;50:1083–1095.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Papadaki T, Pontikoglou C, et al. Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia. Leukemia. 2008;22:1446–1449.
   PubMed Web of Science ®Google Scholar
• Rose A, Isenalumhe L, Bergh M, et al. Clonal T-cell large granular lymphocytic disorders manifesting in patients with HIV-1 infection : case series and review of the literature. Mediterr J Hematol Infect Dis. 2018;10(1):6–10.
   Web of Science ®Google Scholar
• Sokol L, Loughran TP. Large granular lymphocyte leukemia. The Oncologist. 2006;11:263–273.
   PubMed Web of Science ®Google Scholar
• O'Keefe CL, Plasilova M, Wlodarski M, et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol. 2004;172:1960–1969.
   PubMed Web of Science ®Google Scholar
• Lamy T, Moignet A, Loughran TP. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129:1082–1094.
   PubMed Web of Science ®Google Scholar
• Ghia P, Prato G, Stella S, et al. Age-dependent accumulation of monoclonal CD4 + CD8+ double positive T lymphocytes in the peripheral blood of the elderly. Br J Haematol. 2007;139:780–790.
   PubMed Web of Science ®Google Scholar
• Wack A, Cossarizza A, Heltai S, et al. Age-related modifications of the human alpha-beta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol. 1998;10:1281–1288.
   PubMed Web of Science ®Google Scholar
• Mohty M, Faucher C, Vey N, et al. Features of large granular lymphocytes (LGL) expansion following allogenic stem cell transplantation: a long-term analysis. Leukemia. 2002;16:2129–2133.
   PubMed Web of Science ®Google Scholar
• Kim D, Al-Dawsari G, Chang H, et al. Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT. Bone Marrow Transplant. 2013;48:1104–1111.
   PubMed Web of Science ®Google Scholar
• Nann-Rütti S, Tzankov A, Cantoni N, et al. Large granular lymphocyte expansion after allogeneic hematopoietic stem cell transplant is associated with a cytomegalovirus reactivation and shows an indolent outcome. Biol Blood Marrow Transplant. 2012;18:1765–1770.
   PubMed Web of Science ®Google Scholar
• Berrie JL, Kmieciak M, Sabo RT, et al. Distinct oligoclonal t cells are associated with graft versus host disease after stem-cell transplantation. Transplantation. 2012;93:949–957.
   PubMed Web of Science ®Google Scholar
• Gill H, Ip AHW, Leung R, et al. Indolent T-cell large granular lymphocyte leukaemia after haematopoietic SCT: a clinicopathologic and molecular analysis. Bone Marrow Transplant. 2012;47:952–956.
   PubMed Web of Science ®Google Scholar
• Papalexandri A, Stalika E, Iskas M, et al. Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases. Bone Marrow Transplant. 2013;48:1260–1261.
   PubMed Web of Science ®Google Scholar
• Seggewiss R, Einsele H, Dc W. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation : an update review article immune reconstitution after allogeneic transplantation and expanding options for immunomodulation : an update. Blood. 2010;115:3861–3868.
   PubMed Web of Science ®Google Scholar
• Gress RE, Emerson SG, Drobyski WR. Immune reconstitution: how it should work, what's broken, and why it matters. Biol Blood Marrow Transplant. 2010;16:S133–S137.
   PubMedGoogle Scholar
• Clark JR, Scott SD, Jack AL, et al. Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service. Br J Haematol. 2015;168:26–37.
   PubMed Web of Science ®Google Scholar
• van Dongen JJM, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• Vardi A, Agathangelidis A, Stalika E, et al. Antigen selection shapes the T-cell repertoire in chronic lymphocytic leukemia. Clin Cancer Res. 2016;22:167–174.
   PubMed Web of Science ®Google Scholar
• Kanda J, Chiou LW, Szabolcs P, et al. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18:1664–1676.e1.
   PubMed Web of Science ®Google Scholar
• Yew PY, Alachkar H, Yamaguchi R, et al. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015;50:1227–1234.
   PubMed Web of Science ®Google Scholar
• Stasi R, Del Poeta G, Stipa E, et al. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood. 2007;110:2924–2930.
   PubMed Web of Science ®Google Scholar
• Stalika E, Kanellis G, Papalexandri A, et al. Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma. Leuk Lymphoma. 2014;55:1–5.
   PubMed Web of Science ®Google Scholar
• Tonelli AR, Lottenberg R, Allan RW, et al. Rituximab-induced hypersensitivity pneumonitis. Respiration. 2009;78:225–229.
   PubMed Web of Science ®Google Scholar
• Burton C, Kaczmarski R, Riaz J-M. Interstitial pneumonitis related to rituximab therapy neutropenia in patients treated with Rituximab. N Engl J Med 2003;2690–2691.
   PubMed Web of Science ®Google Scholar
• Rangarajan H, Yassai M, Subramanian H, et al. Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease. Blood. 2012;119:6354–6364.
   PubMed Web of Science ®Google Scholar
• Chang H, Kamel-Reid S, Hussain N, et al. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. Am J Clin Pathol. 2005;123:196–199.
   PubMed Web of Science ®Google Scholar
• Lopez JEH, Yabe M, Carballo-Zarate AA, et al. Donor-derived T-cell large granular lymphocytic leukemia in a patient with peripheral T-cell lymphoma. J Natl Compr Canc Netw. 2016;14:939–944.
   PubMed Web of Science ®Google Scholar
• Nakagawa N, Yamazaki H, Aoki G, et al. Late graft rejection in association with T-large granular lymphocyte expansion of recipient origin after human leukocyte antigen-haploidentical stem cell transplantation: a case report. Transplant Proc. 2016;48:3222–3224.
   PubMed Web of Science ®Google Scholar
• Goyal T, Thakral B, Wang SA, et al. T-cell large granular lymphocytic leukemia and coexisting B-cell lymphomas: a study from the bone marrow pathology group. Am J Clin Pathol. 2018;149:164–171.
   PubMed Web of Science ®Google Scholar